Drug recall · March 11, 2026
Midodrine Hydrochloride Tablets recall
Why: Defective container; inadequately sealed blister packaging.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Midodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets (5 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA, NDC 0904-6818-06.
- Lots / codes
Lot # N02640, Exp Date: 08/2027
- Quantity
- 8892 cartons
- Company
- The Harvard Drug Group LLC, Dublin, OH
- Distribution
- Nationwide US.
- Initiated
- February 17, 2026 · Voluntary: Firm initiated
- Classified
- March 3, 2026
- Reported
- March 11, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Midodrine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.